Greenway Greenhouse's cultivation facility in Leamington, Ontario, has received CUMS-GAP and GACP certification. This demonstrates that the facility meets strict international standards, providing the company a way to distribute its product internationally.
"Receiving these certifications opens up a whole new world of opportunities for Greenway. We have been talking to companies that export into multiple countries around the world, who are eager to work with us to bring Greenway's cannabis to the global market," said Jamie D'Alimonte, CEO of Greenway. "With our most recent expansion, we are able to scale up production to meet any new demand for our product internationally. These new sales opportunities should help us increase our revenue, gross margins, and be a key cog in achieving true profitability."
"Canadian medical cannabis is highly regarded, and in great demand around the world," said Carl Mastronardi, President of Greenway. "The export market offers new sales routes for our high-quality products, which we believe may lead to Greenway receiving a higher average sales price than the current domestic market will support. Our goal is for international sales to becomes a regular and significant part of our revenue makeup."
Greenway's cultivation facility is designed for high-quality, low-cost production, and has an annual cultivation capacity of 24,000 kg. The CUMS-GAP certificate and GACP compliance certificate follow the WHO and EMA GACP guidelines, with the certification being completed through Control Union. These certifications mean that all cannabis that begins to be grown, as of April 17, 2024, meets the criteria to be distributed to certain countries outside Canada.
For more information:
Greenway Greenhouse
www.greenway.ca